ConserV Bioscience Limited

FDA Places Limits On GSK/Vir’s Xevudy The US Food and Drug Administration has moved to limit the use of GlaxoSmithKline plc / Vir Biotechnology, Inc. ’s Xevudy (sotrovimab) in places where SARS-CoV-2

UK-based ConserV Bioscience Limited believes its mission to develop effective vaccines that protect against endemic and emergent infectious diseases will be greatly boosted through an R&D collaborat